Lactiga received a multi-year, multi-million dollar grant from NIH’s NIAID to advance its mucosal-targeted secretory IgA therapy for immunodeficient patients.
Round Type
Grant
North BrunswickBiotechnologyHealth CareTherapeuticsDescription
Lactiga has been awarded a competitive grant from the National Institutes of Health to support the development of its lead asset, LCTG-001, aimed at treating immunodeficient conditions. This funding will help advance key studies towards first-in-human trials for a groundbreaking mucosal-targeted therapy.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Lactiga that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
- StimOxyGen raised $2M on March 11, 2025.
- HelloBetter raised $6.4M (Funding Round) on March 5, 2025.
- TRIMTECH Therapeutics raised $31M (Seed) on March 5, 2025.
- Whitehawk Therapeutics, Inc. raised $100M on March 4, 2025.
- Callio Therapeutics raised $187M (Series A) on March 3, 2025.
Who to call at Lactiga, and when
A new round usually means Lactiga is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lactiga raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lactiga, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lactiga. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lactiga raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lactiga raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.